Company Summary

Sublimity Therapeutics Holdco Limited was set up on Tuesday the 12th of December 2017. Their current partial address is Dublin, and the company status is Liquidation. The company's current directors have been the director of 22 other Irish companies between them; 10 of which are now closed. Sublimity Therapeutics Holdco Limited has 7 shareholders.

Company Name:Sublimity Therapeutics Holdco Limited
Company Status:LIQUIDATION
MEETING OF CREDITORS
Took place on 19/04/2021
Company Address:Dcu Alpha,
Innovation Campus Old Finglas Road,
Dublin 11 Ireland,
Dublin 11,Dublin
Key Executive:Mr Parker
Company Size:Log-In To View

Key Contact Profile

Mr Parker is a Company Director of Sublimity Therapeutics Holdco Limited since 2018 and a listed Director of 2 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Sublimity Therapeutics Holdco Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up18/10/202203/11/2022Join Up
Form E3: Liquidator`s Accounts of Acts & Dealings18/04/202224/05/2022Join Up
Liquidator`s Report of Acts & Dealings18/04/202224/05/2022Join Up
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up18/04/202203/05/2022Join Up
B10 CHANGE IN DIRECTORS/SECRETARY06/03/202231/03/2022Join Up
THIS COMPANY HAS 74 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Sublimity Therapeutics Holdco Limited.

Company Status:Liquidation
MEETING OF CREDITORS
Took place on 19/04/2021
Latest Credit Movement:
Date of Last Movement:16/12/2021
Latest Accounts Filed:09/02/2021
Report Based on Accounts:31/12/2019
Next Set of Accounts Due:30/09/2021
Overdue:Yes
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Sublimity Therapeutics Holdco Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Sublimity Therapeutics Holdco Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Sublimity Therapeutics Holdco Limited and Anti-Money Laundering checks (AML checks) on Sublimity Therapeutics Holdco Limited

Directors details are available to logged in users.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:7

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Sublimity Therapeutics Holdco Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

How 'Green' is your company

02/12/2022

If you're not 100% sure. You are not on your own. Many companies have an objective to become 'greener' or more sustainable.

Read More »

A Shift In Companies Behaviours In Order To Comply With A New Directive

28/11/2022

Companies across Europe are now beginning to change their behaviour in order to comply with a new directive issued by the European Commission (CSRD). Prior to this, companies opted to become more sustainable for reputational reasons.

Read More »

We'd like to introduce you to Synesgy.com

22/11/2022

Being a sustainable business now brings many advantages both environmentally and commercially.

Read More »

Risk Management with Link2Bank

11/11/2022

Companies around Ireland are completing risk management assessments now more than ever, due to the predicted volatility of the economy in the months ahead.

Read More »